HNPP
MCID: HRD054
MIFTS: 33

Hereditary Neuropathy with Liability to Pressure Palsy (HNPP) malady

Categories: Rare diseases, Neuronal diseases, Genetic diseases

Aliases & Classifications for Hereditary Neuropathy with Liability to Pressure Palsy

Aliases & Descriptions for Hereditary Neuropathy with Liability to Pressure Palsy:

Name: Hereditary Neuropathy with Liability to Pressure Palsy 50
Hereditary Liability to Pressure Palsies 69
Polyneuropathy, Familial Recurrent 50
Tomaculous Neuropathy 50
Hnpp 50

Classifications:



Summaries for Hereditary Neuropathy with Liability to Pressure Palsy

NIH Rare Diseases : 50 hereditary neuropathy with liability to pressure palsy (hnpp) is a disorder that affects peripheral nerves. this condition causes recurrent episodes of numbness, tingling, and/or loss of muscle function (palsy). an episode can last from several minutes to several months, but recovery is usually complete. repeated incidents, however, can cause permanent muscle weakness or loss of sensation. the most common problem sites involve nerves in wrists, elbows, and knees. symptoms usually begin during adolescence or early adulthood but may develop anytime from childhood to late adulthood. symptoms vary in severity; many people never realize they have the disorder, while some people experience prolonged disability. this condition is caused by the loss of one copy of the pmp22 gene or alterations within the gene. it is inherited in an autosomal dominant  manner. last updated: 7/24/2015

MalaCards based summary : Hereditary Neuropathy with Liability to Pressure Palsy, also known as hereditary liability to pressure palsies, is related to neuropathy, recurrent, with pressure palsies and mononeuropathy of the median nerve, mild. An important gene associated with Hereditary Neuropathy with Liability to Pressure Palsy is PMP22 (Peripheral Myelin Protein 22), and among its related pathways/superpathways is Neural Crest Differentiation. The drugs Prednisolone and Lidocaine have been mentioned in the context of this disorder. Affiliated tissues include testes.

Wikipedia : 71 Hereditary Neuropathy with Liability to Pressure Palsy (HNPP) is a peripheral neuropathy, a disorder of... more...

Related Diseases for Hereditary Neuropathy with Liability to Pressure Palsy

Diseases related to Hereditary Neuropathy with Liability to Pressure Palsy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 62)
id Related Disease Score Top Affiliating Genes
1 neuropathy, recurrent, with pressure palsies 12.2
2 mononeuropathy of the median nerve, mild 11.2
3 neuropathy 11.1
4 hereditary neuropathies 11.1
5 charcot-marie-tooth disease 10.6
6 tooth disease 10.6
7 charcot-marie-tooth disease, type 1a 10.5
8 plexopathy 10.3
9 foot drop 10.1
10 polyneuropathy 10.1
11 lateral sclerosis 10.1
12 childhood infratentorial neoplasm 10.1 LITAF PMP22
13 polyradiculoneuropathy 10.0
14 chronic inflammatory demyelinating polyradiculoneuropathy 10.0
15 oculopharyngeal muscular dystrophy 10.0
16 influenza 10.0
17 muscular dystrophy 10.0
18 schwannomatosis 10.0
19 pelizaeus-merzbacher disease 10.0
20 myoclonus 10.0
21 sciatic neuropathy 10.0
22 mononeuropathy 10.0
23 bell's palsy 10.0
24 brachial plexus neuropathy 10.0
25 aortic aneurysm, familial thoracic 4 10.0 LITAF MPZ
26 craniorachischisis 10.0 MPZ PMP22
27 chrna1-related congenital myasthenic syndrome 10.0 MPZ PMP22
28 surfactant metabolism dysfunction, pulmonary, 2 10.0 MPZ PMP22
29 hypertonia 10.0 MPZ PMP22
30 pneumonic plague 9.9 MPZ PMP22
31 deafness, autosomal recessive 76 9.9 MPZ PMP22
32 hypertrophic osteoarthropathy, primary, autosomal recessive 2 9.9 MPZ PMP22
33 neuropathy, inflammatory demyelinating 9.9 MPZ PMP22
34 acute sanguinous otitis media 9.9 MPZ PMP22
35 dejerine-sottas disease 9.9 MPZ PMP22
36 nephrolithiasis, uric acid 9.9 MPZ PMP22
37 chkb-related muscle diseases 9.9 MPZ PMP22
38 infantile epileptic encephalopathy 9.9 MPZ PMP22
39 charcot-marie-tooth disease, type 1e 9.9 MPZ PMP22
40 von economo's disease 9.9 MPZ PMP22
41 pituitary adenoma, prolactin-secreting 9.9 MPZ PMP22
42 mohr-tranebjaerg syndrome 9.9 MPZ PMP22
43 non-gestational choriocarcinoma 9.9 MPZ PMP22
44 korsakoff's amnesic syndrome 9.9 MPZ PMP22
45 choreatic disease 9.9 MPZ PMP22
46 status epilepticus 9.9 MPZ PMP22
47 thrombophilia due to antithrombin iii deficiency 9.9 MPZ PMP22
48 uterine ligament serous adenocarcinoma 9.9 MPZ PMP22
49 dilated cardiomyopathy 9.9 MPZ PMP22
50 conotruncal heart malformations 9.8 MPZ PMP22

Graphical network of the top 20 diseases related to Hereditary Neuropathy with Liability to Pressure Palsy:



Diseases related to Hereditary Neuropathy with Liability to Pressure Palsy

Symptoms & Phenotypes for Hereditary Neuropathy with Liability to Pressure Palsy

Drugs & Therapeutics for Hereditary Neuropathy with Liability to Pressure Palsy

Drugs for Hereditary Neuropathy with Liability to Pressure Palsy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 200)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Prednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3 50-24-8 5755
2
Lidocaine Approved, Vet_approved Phase 4,Phase 2,Phase 3 137-58-6 3676
3
Bupivacaine Approved, Investigational Phase 4 2180-92-9, 38396-39-3 2474
4
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3 83-43-2 6741
5
Gabapentin Approved, Investigational Phase 4,Phase 3 60142-96-3 3446
6
Acetaminophen Approved Phase 4,Phase 2 103-90-2 1983
7
Ketorolac Approved Phase 4 74103-06-3, 66635-83-4 3826
8
Triamcinolone Approved, Vet_approved Phase 4,Phase 2,Phase 3 124-94-7 31307
9
Ropivacaine Approved Phase 4 84057-95-4 71273 175805
10
Ibuprofen Approved Phase 4,Phase 2 15687-27-1 3672
11
Hydrocodone Approved, Illicit Phase 4 125-29-1 5284569
12
Guaifenesin Approved, Vet_approved Phase 4 93-14-1 3516
13
Oxycodone Approved, Illicit, Investigational Phase 4,Phase 2 76-42-6 5284603
14
Vitamin A Approved, Nutraceutical, Vet_approved Phase 4 11103-57-4, 68-26-8 445354
15
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 3 59-30-3 6037
16 Prednisolone acetate Phase 4,Phase 2,Phase 3
17 Analgesics Phase 4,Phase 3,Phase 2
18 glucocorticoids Phase 4,Phase 3,Phase 2
19 Gastrointestinal Agents Phase 4,Phase 2,Phase 3
20 Sodium Channel Blockers Phase 4,Phase 2,Phase 3
21 Neuroprotective Agents Phase 4,Phase 2,Phase 3
22 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1
23 Analgesics, Non-Narcotic Phase 4,Phase 2
24 Hormone Antagonists Phase 4,Phase 3,Phase 2
25 Tranquilizing Agents Phase 4,Phase 3,Phase 2
26 Anesthetics Phase 4,Phase 2,Phase 3
27 Hormones Phase 4,Phase 3,Phase 2
28 Diuretics, Potassium Sparing Phase 4,Phase 2,Phase 3
29 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Phase 1
30 Anesthetics, Local Phase 4,Phase 2,Phase 3
31 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2
32 Anti-Arrhythmia Agents Phase 4,Phase 2,Phase 3
33 Prednisolone hemisuccinate Phase 4,Phase 2,Phase 3
34 Prednisolone phosphate Phase 4,Phase 2,Phase 3
35 Anticonvulsants Phase 4,Phase 3
36 Protective Agents Phase 4,Phase 2,Phase 3
37 Antiemetics Phase 4,Phase 2,Phase 3
38 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2
39 Psychotropic Drugs Phase 4,Phase 3,Phase 2
40 Antimanic Agents Phase 4,Phase 3
41 Respiratory System Agents Phase 4,Phase 3
42 Methylprednisolone acetate Phase 4,Phase 2,Phase 3
43 Methylprednisolone Hemisuccinate Phase 4,Phase 2,Phase 3
44 Autonomic Agents Phase 4,Phase 2,Phase 3
45 Antineoplastic Agents, Hormonal Phase 4,Phase 2,Phase 3
46 Central Nervous System Depressants Phase 4,Phase 3,Phase 2
47 triamcinolone acetonide Phase 4,Phase 2,Phase 3
48 calcium channel blockers Phase 4,Phase 3
49 GABA Agents Phase 4,Phase 3
50 Cyclooxygenase Inhibitors Phase 4,Phase 2

Interventional clinical trials:

(show top 50) (show all 230)
id Name Status NCT ID Phase
1 Postoperative Alpha Lipoic Acid in the Carpal Tunnel Syndrome: a Randomized Controlled Trial. Completed NCT01895621 Phase 4
2 Bupivacaine Versus Lidocaine Local Anesthesia Completed NCT01751347 Phase 4
3 Length of Post Operative Dressing After Carpal Tunnel Release Completed NCT01310218 Phase 4
4 Patient Controlled Regional Analgesia Following Carpal Tunnel Release: A Double-Blind Study Using Distal Perineural Catheters Completed NCT00678314 Phase 4
5 Pain Outcomes of Intra-operative IV Tylenol and/or IV Toradol for Carpal Tunnel and Distal Radius Fracture Surgeries Completed NCT02313675 Phase 4
6 Efficacy Study of Local Steroid Injection and Wrist Splinting for Carpal Tunnel Syndrome Completed NCT02140632 Phase 4
7 A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions Completed NCT00904202 Phase 4
8 Therapeutic Effects Analysis of Pudendal Nerve Infiltrations After 3 Months, in Patients Suffering of Pudendal Neuralgia Completed NCT00851513 Phase 4
9 Short and Long Term Exposure to Unique, Time-Varying Pulsed Electro-Magnetic Fields in Refractory Carpal Tunnel Syndrome Completed NCT00277563 Phase 4
10 Narcotic vs. Non-narcotic Pain Study Protocol Recruiting NCT01974609 Phase 4
11 Injection Versus Splinting in Carpal Tunnel Syndrome Active, not recruiting NCT02038452 Phase 4
12 Post-operative Analgesia in Elective, Soft-tissue Hand Surgery Enrolling by invitation NCT02029235 Phase 4
13 Local Steroid Injection vs Placebo in Carpal Tunnel Syndrome Enrolling by invitation NCT02652390 Phase 4
14 Patient Satisfaction With Pain Relief After Ambulatory Hand Surgery Terminated NCT01588158 Phase 4
15 Lidocaine and Triamcinolone vs Saline Trigger Point Injection for Treatment of Chronic Abdominal Wall Pain Withdrawn NCT02748395 Phase 4
16 Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot−Marie−Tooth Neuropathy Type 1A (CMT1A) Unknown status NCT01289704 Phase 2, Phase 3
17 Carpal Tunnel Syndrome Release Using PSU Retractor Unknown status NCT01017471 Phase 3
18 High Dose Ascorbic Acid Treatment of CMT1A Completed NCT00484510 Phase 2, Phase 3
19 Sonographic Examination Cubital Tunnel Release Completed NCT02739945 Phase 3
20 Sonography-guided Steroid Injection for Carpal Tunnel Syndrome Completed NCT02575729 Phase 3
21 Preoperative Gabapentine for Carpal Tunnel Completed NCT01632215 Phase 3
22 Steroid Injection Treatment of Carpal Tunnel Syndrome Completed NCT00806871 Phase 2, Phase 3
23 Gabapentin for Carpal Tunnel Syndrome Completed NCT00137735 Phase 3
24 Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid Completed NCT00007020 Phase 3
25 Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Recruiting NCT03023540 Phase 3
26 Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome Recruiting NCT02141035 Phase 2, Phase 3
27 Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity Recruiting NCT03013543 Phase 2, Phase 3
28 Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) Active, not recruiting NCT02579759 Phase 3
29 Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia Active, not recruiting NCT02604186 Phase 2, Phase 3
30 Assessment of the Effectiveness of Ultrasound-guided Acupuncture in the Management of Carpal Tunnel Syndrome Not yet recruiting NCT02870673 Phase 2, Phase 3
31 Erythropoietin Spinal Cord Compression Randomized Trial Terminated NCT00220675 Phase 2, Phase 3
32 NeuroPath Comparative Validation Study Plan Terminated NCT00393549 Phase 3
33 A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Minor Surgical Procedures Terminated NCT00209560 Phase 3
34 Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome Terminated NCT00266214 Phase 3
35 Patient Outcomes With Endoscopic Versus Open Carpal Tunnel Release Unknown status NCT00880295 Phase 2
36 Minocycline to Reduce Pain After Carpal Tunnel Release Unknown status NCT02051296 Phase 2
37 Carpal Tunnel Syndrome and Static Magnetic Field Therapy Unknown status NCT00521495 Phase 2
38 Carpal Tunnel Syndrome Treated With 830nm Diode Laser Unknown status NCT00514462 Phase 1, Phase 2
39 Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease Completed NCT00541164 Phase 1, Phase 2
40 Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease Completed NCT02561702 Phase 2
41 Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A Completed NCT01401257 Phase 2
42 Ascorbic Acid Treatment in CMT1A Trial (AATIC) Completed NCT00271635 Phase 2
43 The Treatment of the Median Nerve for the Elimination of the Symptoms Associated With the Carpal Tunnel Syndrome Completed NCT00634738 Phase 1, Phase 2
44 Comparison of Effect of Anterior Subcutaneous and Submuscular Transposition on Cubital Tunnel Syndrome Completed NCT01109901 Phase 2
45 Treatment for Cubital Tunnel Syndrome Completed NCT00184158 Phase 2
46 Treatment of Thoracic Outlet Syndrome (TOS) With Botox Completed NCT00444886 Phase 2
47 Acute Human Study: StimRouter for Peripheral Nerve Stimulation of Discrete Peripheral Nerves Completed NCT00665132 Phase 1, Phase 2
48 Sham Device, Pill Placebo or Treatment For Arm Pain Completed NCT00029497 Phase 2
49 Percutaneous Treatment of Carpal Tunnel Syndrome With Scan Completed NCT02514317 Phase 2
50 Fascial Manipulation on the Treatment of Carpal Tunnel Syndrome Completed NCT02495298 Phase 2

Search NIH Clinical Center for Hereditary Neuropathy with Liability to Pressure Palsy

Genetic Tests for Hereditary Neuropathy with Liability to Pressure Palsy

Anatomical Context for Hereditary Neuropathy with Liability to Pressure Palsy

MalaCards organs/tissues related to Hereditary Neuropathy with Liability to Pressure Palsy:

39
Testes

Publications for Hereditary Neuropathy with Liability to Pressure Palsy

Articles related to Hereditary Neuropathy with Liability to Pressure Palsy:

(show top 50) (show all 195)
id Title Authors Year
1
Clinical and neurophysiological features of the hereditary neuropathy with liability to pressure palsy due to the 17p11.2 deletion. ( 26982985 )
2016
2
[Molecular genetic diagnosis and clinical features of hereditary neuropathy with liability to pressure palsies in Belarusian patients]. ( 26977628 )
2016
3
Hereditary neuropathy with liability to pressure palsy presenting as a bilateral brachial plexopathy. ( 26874568 )
2016
4
The broad clinical spectrum of hereditary neuropathy with liability to pressure palsy (HNPP). ( 26982983 )
2016
5
Compression of Root Level in a Patient with Hereditary Neuropathy with Liability to Pressure Palsy Diagnosed by Magnetic Resonance Imaging: A Case Report. ( 27149588 )
2016
6
An n-of-one RCT for intravenous immunoglobulin G for inflammation in hereditary neuropathy with liability to pressure palsy (HNPP). ( 26187721 )
2015
7
Mutational analysis of Greek patients with suspected hereditary neuropathy with liability to pressure palsies (HNPP): a 15-year experience. ( 26110377 )
2015
8
Proximal arm weakness is the most common presentation in young Korean soldiers diagnosed as having hereditary neuropathy with liability to pressure palsy (HNPP). ( 26462743 )
2015
9
Partial Gene Deletions of PMP22 Causing Hereditary Neuropathy with Liability to Pressure Palsies. ( 25506001 )
2014
10
Hereditary Neuropathy with Liability to Pressure Palsy Presenting as an Acute Brachial Plexopathy: A Lover's Palsy. ( 25685136 )
2014
11
Sonographic evaluation of the peripheral nerves in hereditary neuropathy with liability to pressure palsies: a case report. ( 24639934 )
2014
12
Characteristic features of hereditary neuropathy with liability to pressure palsy (HNPP) presenting with brachial plexopathy in soldiers. ( 25175852 )
2014
13
Pain in hereditary neuropathy with liability to pressure palsy: An association with fibromyalgia syndrome? ( 25042093 )
2014
14
Clinical, electrophysiological and magnetic resonance findings in a family with hereditary neuropathy with liability to pressure palsies caused by a novel PMP22 mutation. ( 24239057 )
2014
15
Overlap Phenotype between CMT1A and Hereditary Neuropathy with Liability to Pressure Palsies Caused by the Novel Small In-frame Deletion c.407_418del12 in PMP22 Gene. ( 25265422 )
2014
16
Axonal dysfunction, dysmyelination, and conduction failure in hereditary neuropathy with liability to pressure palsies. ( 24752454 )
2014
17
Ultrasonographic findings in hereditary neuropathy with liability to pressure palsies. ( 25005138 )
2014
18
Clinical, electrophysiological, and molecular findings in early onset hereditary neuropathy with liability to pressure palsy. ( 24668782 )
2014
19
Hereditary neuropathy with liability to pressure palsies presenting with sciatic neuropathy. ( 25326571 )
2014
20
Does hereditary neuropathy with liability to pressure palsy predispose to schwannomatosis? ( 25324890 )
2014
21
PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies. ( 24646194 )
2014
22
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) associated to hereditary neuropathy with liability to pressure palsies (HNPP) and revealed after influenza AH1N1 vaccination. ( 24146347 )
2013
23
Comments on 'hereditary neuropathy with liability to pressure palsy: an investigation in a rare and large chinese family'. ( 24192759 )
2013
24
Hereditary neuropathy with liability to pressure palsy: two cases of difficult diagnosis. ( 23965407 )
2013
25
Bell's palsy and hereditary neuropathy with liability to pressure palsy (HNPP): is there a common genetic background? ( 23635862 )
2013
26
Hereditary neuropathy with liability to pressure palsy: a recurrent and bilateral foot drop case report. ( 24251057 )
2013
27
Hereditary Neuropathy with Liability to Pressure Palsy: global neuropathy after tourniquet use. ( 24080438 )
2013
28
Hereditary neuropathy with liability to pressure palsy: fulminant radicular dysfunction during anterolateral lumbar interbody fusion. ( 23881104 )
2013
29
Rapid genetic screening of Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies patients. ( 25337104 )
2012
30
Hereditary neuropathy with liability to pressure palsy presenting with hand drop in a young child. ( 22953141 )
2012
31
Sonographic features in hereditary neuropathy with liability to pressure palsies. ( 22581553 )
2012
32
Hereditary neuropathy with liability to pressure palsy combined with suspected schwannomas of the peroneal and radial nerves. ( 22037956 )
2012
33
Massive indoor cycling-induced rhabdomyolysis in a patient with hereditary neuropathy with liability to pressure palsy. ( 23240383 )
2012
34
Two cases of elderly-onset hereditary neuropathy with liability to pressure palsy manifesting bilateral peroneal nerve palsies. ( 23185166 )
2012
35
Hereditary neuropathy with liability to pressure palsy: an investigation in a rare and large Chinese family. ( 23147806 )
2012
36
Coexistence of transthyretin familial amyloid polyneuropathy and hereditary neuropathy with liability to pressure palsy. ( 22520972 )
2012
37
Hereditary neuropathy with liability to pressure palsy: a brief review with a case report. ( 22023293 )
2012
38
Beneficial use of steroids in hereditary neuropathy with liability to pressure palsy. ( 22098098 )
2012
39
A novel small deletion in PMP22 causes a mild hereditary neuropathy with liability to pressure palsies phenotype. ( 22190321 )
2012
40
Hereditary neuropathy with liability to pressure palsies. Diagnosis in the first family (1947) confirmed. ( 23279343 )
2012
41
Sonographic and electrodiagnostic features of hereditary neuropathy with liability to pressure palsies. ( 23279340 )
2012
42
Hereditary neuropathy with liability to pressure palsies occurring during military training. ( 22545374 )
2012
43
Sonographic features in hereditary neuropathy with liability to pressure palsies. ( 22102454 )
2011
44
Thermosensitive hereditary neuropathy with liability to pressure palsy. ( 21321961 )
2011
45
Mutation analysis of PMP22 in Slovak patients with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies. ( 22131320 )
2011
46
A report of hereditary neuropathy with liability to pressure palsy (HNPP) presenting with brachial plexopathy: the value of complete electrodiagnostic testing. ( 21988036 )
2011
47
Rapidly progressive amyotrophic lateral sclerosis in a young patient with hereditary neuropathy with liability to pressure palsies. ( 19437170 )
2010
48
Ultrasound aids in the diagnosis of hereditary neuropathy with liability to pressure palsies. ( 18440055 )
2009
49
Hereditary neuropathy with liability to pressure palsy (HNPP) in childhood: a case study emphasizing the relevance of detailed electrophysiological examination for suspected HNPP in the first decade. ( 18760885 )
2009
50
A newly identified Thr99fsX110 mutation in the PMP22 gene associated with an atypical phenotype of the hereditary neuropathy with liability to pressure palsies. ( 19830275 )
2009

Variations for Hereditary Neuropathy with Liability to Pressure Palsy

Copy number variations for Hereditary Neuropathy with Liability to Pressure Palsy from CNVD:

7
id CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 106962 17 10700000 16000000 Copy number Hereditary neuropathy with liability to pressure palsy

Expression for Hereditary Neuropathy with Liability to Pressure Palsy

Search GEO for disease gene expression data for Hereditary Neuropathy with Liability to Pressure Palsy.

Pathways for Hereditary Neuropathy with Liability to Pressure Palsy

Pathways related to Hereditary Neuropathy with Liability to Pressure Palsy according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 10.63 MPZ PMP22

GO Terms for Hereditary Neuropathy with Liability to Pressure Palsy

Cellular components related to Hereditary Neuropathy with Liability to Pressure Palsy according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 lysosome GO:0005764 8.62 LITAF MPZ

Biological processes related to Hereditary Neuropathy with Liability to Pressure Palsy according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 chemical synaptic transmission GO:0007268 8.96 MPZ PMP22
2 myelination GO:0042552 8.62 MPZ PMP22

Sources for Hereditary Neuropathy with Liability to Pressure Palsy

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....